This program includes complimentary ship and shore engineering assistance with incentive / rebate
program applications in order to encourage plastic manufacturers to produce their products responsibly, efficiently, and effectively... Read More
Not exact matches
Linda Blaser, a contract recruiter for Exchange
Applications, an IT company
in Boston, has set up a referral
program that gives employees more money for more valuable referrals: $ 3,000 for most positions and $ 5,000 for «hot jobs» that Blaser needs to fill with particular urgency.
In the
application, Berkshire said that it did not buy new shares, but hit the threshold due to the buyback
program of Wells.
Cases
in point: Multiple versions with negligible feature differences are offered, you have to manually backup and reinstall data to upgrade from Windows XP, and certain
programs (including e-mail and calendar
applications) must be downloaded separately from the OS.
ENJOINED AND RESTRAINED from,
in any manner or by any means, removing individuals with refugee
applications approved by U.S. Citizenship and Immigration Services as part of the U.S. Refugee Admissions
Program, holders of valid immigrant and non-immigrant visas, and other individuals from Iraq, Syria, Iran, Sudan, Libya, Somalia, and Yemen legally authorized to enter the United States.
The Tesla's «
in - vehicle infotainment system» lacks an
application programming interface — a way for programmers to tap into a computer system and write apps for it.
TechStars is loosely affiliated with 30 of these
programs -; serving
in an advisory capacity and allowing the
programs to use its
application -; and it runs TechStars
programs in New York City, Boston, Seattle, San Antonio, and Boulder.
For those loan
programs that do close down, the SBA will establish an online queue where small - business loan
applications will be stacked
in order that they are received.
Lotus 1 -2-3's cousin, Lotus Notes — which offered companies integrated messaging, business
applications and social collaboration
in one workspace — was the
program that caught IBM's eye; Lotus 1 -2-3 simply tagged along because it was family.
Carly Gloge, a Canadian website and
application design professional and the co-founder of Ubooly, got her sea legs with the toy at the famous TechStars accelerator
program in Boulder
in the summer of 2012.
The Social Security Administration received nearly 2.7 million
applications for the
program in 2013, up from 1.9 million a decade earlier, according to its most recent annual report.
Applications have climbed from 11
in 2010 — the
program's first year — to 36 this summer.
In 1999, IDBs, previously considered an option for only large companies seeking multimillion - dollar loans, got a sleek new look with the creation of the mini-bond
program, which offers a streamlined
application process, capped fees and quick closings.
When HP tapped L?o Apotheker, the former CEO of SAP, Oracle's archrival
in business -
application programs, as its new commander -
in - chief, Ellison charged HP with «[picking] a guy who was recently fired because he did such a bad job of running SAP,» and called for the board's immediate, «en masse» resignation.
Such drives usually come with a built -
in pop - up
program launcher called LaunchPad and a few
programs, or they at least link to a Web page for downloading and installing free and for - pay U3
applications.
Earlier this month, it was revealed the number of
applications for H - 1B visas — a similar, coveted
program for companies to onboard specialized foreign labor — declined for the second year
in a row, as the administration moves to streamline the
program.
Individual or individuals making the
application have a record of successful performance of contract work
in the past, provided that those contracts (which may be from either government or private clients) are
in the primary industry category
in which the applicant is seeking
program certification.
Google just announced it is buying Apigee, a specialist
in application programming interfaces (APIs), for approximately $ 625 million
in cash.
That's why
in 2012 they launched New York City - based Temboo, a repository of
programming processes that developers can use to connect to code utilities, databases and more than 100
application programming interfaces (APIs) for online services ranging from Amazon Web Services cloud storage to real - estate site Zillow.
Not all admissions officers say this will help an
application get approved, but it shows your interest and engagement
in the school's MBA
program, which is exactly what they want to see.
Malware can be hidden, not just
in applications or installation
programs, but
in what appear to be image and video files also.
Early
in his career, Taylor helped create Google Maps and its
application programming interface.
A time when
applications to most two - year MBA
programs are down, there's renewed and growing interest
in accelerated
programs.
Earlier
in her career, she worked at the Centre for Addiction and Mental Health
in Toronto, where she helped develop Ontario's Reduce Impaired Driving Everywhere (RIDE)
program, but she was drawn to the
application of psychology
in management.
For example, many content - management systems have add - ons or plug -
ins for mobile or social
applications, such as a
program that allows visitors to use their saved profile to register with your website rather than creating a new one.
Alternately, Antonopoulos suggests thinking of the «Bitcoin blockchain as having an API» (
application programming interface) that makes its data usable by third parties,
in the same way that second - layer services like Buffer or Hootsuite use the Twitter API to present and interact with Twitter data
in slightly modified or reorganized forms.
The tech titan's BizSpark
program, which offered thousands of dollars
in free cloud credits, along with free access to Office 365 and Microsoft's Visual Studio developer tools, is no longer accepting new
applications, and the company will be eliminating it once the benefits expire for companies already
in the
program.
Clio first opened up the platform
in 2012 and
in the past year «really doubled down» on its positioning, introducing a new
application programming interface (API) that presented additional opportunities for developers.
The
application's instructions are clear:
In order to be accepted into TechStars, the prestigious accelerator
program, start - up founders are asked to submit two videos — one to describe the company's product or service, and the other to introduce the team.
Applications to MBA
programs went up 58 %
in 2015, according to Canada's Graduate Management Admission Council.
«The Commission will not take adverse action on a license renewal
application based upon the subjective determination of a listener or group of listeners that the station has broadcast purportedly inappropriate
programming,» the FCC commissioners wrote
in a recent decision challenging a local radio station license.
As Microsoft's Windows demonstrated
in the PC era, technology markets
in which third - party companies build
programs or
applications to run on top of a particular operating system or other product --» platform markets» — tend to standardize around one or two market leaders.
In the wake of last year's results, the Liberals moved up the opening of the application period, then extended it by two weeks in January when it looked like there would be a shortfall in businesses applying for the progra
In the wake of last year's results, the Liberals moved up the opening of the
application period, then extended it by two weeks
in January when it looked like there would be a shortfall in businesses applying for the progra
in January when it looked like there would be a shortfall
in businesses applying for the progra
in businesses applying for the
program.
The last element of the industry — the popular
application program — didn't begin to fall into place until a meeting occurred between Dan Bricklin and Dan Fylstra
in Boston
in 1978.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug
applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Many
applications development manager roles require candidates to have strong
programming and analytical skills, as well as a bachelor's degree
in computer science or engineering.
The
program, which they named VisiCalc and introduced
in October 1979, turned into the best - selling
application program in history, with about 200,000 copies sold to date.
You may also authorize us to share your information with others, for example, with a third - party
application when you give it access to your account, or with your employer when you choose to participate
in an employee wellness
program.
These
programs allow self - employed individuals with significant experience
in certain trades and professions to make an
application for Canadian immigration.
There are a number of reasons for Amazon's newfound energy
in advertising: It is doing more outreach with Madison Avenue, striking deals with holding companies and agencies; it opened an ad platform last year, an
application programming interface that lets marketing developers build easier ways to buy ads; and it is opening its Amazon Ad Platform to more brands.
To this end, it offers short - term Junior Research Fellowships on an ongoing basis to Canadians who are currently enrolled
in undergraduate or master's - level
programs, or who have completed their degree
programs within 12 months of the
application deadline.
The MaRS clients chosen to participate
in the
program produce a range of technology
applications:
What separates decentralized
applications from standard
applications is the infrastructure of their back - end servers, omitting the use of
programming languages such as Rails or Django
in favor of blockchain technology — removing centralized hosting services and putting power and voice back
in the hands of its users.
The Vancouver Board of Trade is also pleased to see the investment
in application processing by the NEB, and a continued commitment to workforce training and strengthening Canada's labour market, including the creation of the Canada Apprentice Loan
program and assistance for persons with disabilities.
July marks the beginning of our annual Entrepreneur Season, when we unveil a full calendar of unique events for the community and open
applications for participation
in our entrepreneur support
programs.
Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug
application (IND) for the company's lead
program, light - activated AU - 011
in ocular melanoma (OM).
They're not necessarily going to be the ones to sit down and code the algorithms, but they have been exposed right
in the
program to what these technologies can do, and see the business
applications.
Applications will be due February 23, 2018, and this year's
program will be held June 17 - 22, 2018 at the WBENC National Conference & Business Fair
in Detroit, MI.
After the
application process for the 4th generation, which took place
in July, 29 young startups have been chosen to be part of the flagship entrepreneurial
program of the Chilean government.
In special instances, Joey offers an
application - only, group coaching
program for up to ten CEOs / entrepreneurs operating within the same industry.